Your browser doesn't support javascript.
loading
Design, Synthesis and Evaluation of 3-Substituted Coumarin Derivatives as Anti-inflammatory Agents.
Wang, Tao; Peng, Tao; Wen, Xiaoxue; Wang, Gang; Liu, Shuchen; Sun, Yunbo; Zhang, Shouguo; Wang, Lin.
Afiliación
  • Wang T; College of Life Science and Bio-engineering, Beijing University of Technology.
  • Peng T; Beijing Institute of Radiation Medicine.
  • Wen X; Beijing Institute of Radiation Medicine.
  • Wang G; Beijing Institute of Radiation Medicine.
  • Liu S; Beijing Institute of Radiation Medicine.
  • Sun Y; Beijing Institute of Radiation Medicine.
  • Zhang S; Beijing Institute of Radiation Medicine.
  • Wang L; Beijing Institute of Radiation Medicine.
Chem Pharm Bull (Tokyo) ; 68(5): 443-446, 2020 May 01.
Article en En | MEDLINE | ID: mdl-32173668
Coumarin moiety has garnered momentous attention especially in the design of compounds with significant biological activities. In this work, a series of 3-substituted coumarin derivatives 6a-6l were synthesized and fully characterized. Most of the compounds could obviously inhibit the activity of cyclooxygenase-1 (COX-1) at the concentration of 10 µM. Besides, 6h and 6l exhibited highest inhibitory effects against COX-2 with inhibition rates of 33.48 and 35.71%, respectively. Detailed structure-activity relationships (SARs) were also discussed. In vivo studies, 6b, 6i and 6l could remarkably repress the xylene-induced ear swelling in mice at the dose of 20 mg/kg. Especially, 6l seemed to be the most effective compound at the dose of 10 mg/kg, displaying favorable anti-inflammatory activity comparable to indomethacin. All of these findings suggested that 6l might be utilized as a candidate for the treatment of inflammatory diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diseño de Fármacos / Antiinflamatorios no Esteroideos / Factor de Necrosis Tumoral alfa / Inhibidores de la Ciclooxigenasa / Cumarinas / Enfermedades del Oído Tipo de estudio: Prognostic_studies Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diseño de Fármacos / Antiinflamatorios no Esteroideos / Factor de Necrosis Tumoral alfa / Inhibidores de la Ciclooxigenasa / Cumarinas / Enfermedades del Oído Tipo de estudio: Prognostic_studies Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2020 Tipo del documento: Article